Cite
MLA Citation
Laura J. Klesse et al.. “The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities.” Oncologist, vol. 25, 2020, pp. e1109–e1116. http://access.bl.uk/ark:/81055/vdc_100158314404.0x000017